circRNA basic information
circBase ID: -
Name: hsa_circ_BNC2
Synonym: Circular RNA BNC2 / circBNC2
Host Gene: BNC2
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005140
MONDO name: ovarian carcinoma
Disease details: epithelial ovarian cancer / EOC
Disease DO ID:
4001
Disease MeSH ID:
-
Disease NCIt ID:
C4908
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

epithelial ovarian tumors; adjacent normal tissues; EOC tissues

Cell lines:

IOSE-80; OV90; OVCAR-3; 293T

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: LARP4, Snail1, Slug
Associated microRNA: miR-223-3p
Biological function: circBNC2 acts as a tumor suppressor in EOC; overexpression inhibits cell viability, proliferation, migration, invasion, EMT-related protein expression and tumor growth, and promotes apoptosis and G0/G1 cell-cycle arrest.
Molecular mechanism: circBNC2 functions as a ceRNA sponge for miR-223-3p, thereby positively regulating LARP4 expression and suppressing EOC progression; circBNC2 overexpression also reduces EMT-related proteins Snail1 and Slug.
Biological pathway or process:

ceRNA regulation (other); proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); cell cycle (inhibits); EMT (inhibits); metastasis (inhibits)

Detected method:
Q
Validation methods:

RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Bioinformatics Analysis; Cohort Study

Clinical significance:

circBNC2/miR-223-3p/LARP4 axis may be a potential regulatory mechanism for the treatment of EOC.

Description:

circBNC2 is down-regulated in epithelial ovarian cancer tissues and cell lines and functions as a tumor suppressor. It sponges miR-223-3p to increase LARP4 expression, thereby inhibiting EOC cell proliferation, migration, invasion, EMT-associated protein expression, and xenograft tumor growth while promoting apoptosis.

Confidence score:

0.8467

Other information
Title:

CircBNC2 affects epithelial ovarian cancer progression through the miR-223-3p/ LARP4 axis.

Journal: Anti-cancer drugs
Published: 2023
PubMed ID: 36730544
Study type:

combined biological and clinical study

Data availability: -
Code availability: -